Table 2. Number of TACS designed on critical microdeletion/microduplication regions and on reference chromosomes.
| Syndrome/Overlapping Syndrome | Chr. | Location (GRch37) | Critical Region Size* (Mb) | No. TACS |
|---|---|---|---|---|
| 1p36 microdeletion Syndrome | 1 | 10001–12840259 | 12.83 | 176 |
| Wolf-Hirschhorn Syndrome | 4 | 1569197–2110236 | 0.54 | 70 |
| Miller-Dieker Syndrome | 17 | 1–2588909 | 2.59 | 138 |
| Smith-Magenis Syndrome/ Potocki-Lupski Syndrome | 17 | 16773072–20222149 | 3.45 | 132 |
| NF1 microdeletion Syndrome | 17 | 29107097–30263321 | 1.4 | 99 |
| 22q11.2 deletion Syndrome (Velocardiofacial, DiGeorge syndrome) | 22 | 19009792–21452445 | 2.44 | 140 |
| Total Number of TACS on syndromic regions | 755 | |||
| Total Number of TACS used as Reference Chr1-Chr12 | 490 | |||
* according to DECIPHER Database.